C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet (2009) 11.81

C-reactive protein: a critical update. J Clin Invest (2003) 11.77

Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol (2009) 3.09

International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation (2007) 3.01

Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology (2007) 2.98

Adiponectin as an anti-inflammatory factor. Clin Chim Acta (2007) 2.56

Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status. J Epidemiol Community Health (2003) 2.46

Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes (2005) 2.46

Ambient particulate matter accelerates coagulation via an IL-6-dependent pathway. J Clin Invest (2007) 2.36

High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol (2007) 2.29

Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril (2010) 2.25

Obesity and 1-year outcomes in older Americans with severe sepsis. Crit Care Med (2014) 2.10

Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax (2005) 2.03

Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing (2005) 1.99

Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. CMAJ (2005) 1.90

Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radic Biol Med (2007) 1.84

Effects of etanercept in patients with the metabolic syndrome. Arch Intern Med (2006) 1.82

The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol (2010) 1.79

The association between BMI and plasma cytokine levels in patients with acute lung injury. Chest (2010) 1.75

Low birth weight and markers of inflammation and endothelial activation in adulthood: the ARIC study. Int J Cardiol (2008) 1.73

Depressive symptoms and metabolic syndrome: is inflammation the underlying link? Biol Psychiatry (2008) 1.70

The major inflammatory mediator interleukin-6 and obesity. Inflamm Res (2009) 1.67

Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediators Inflamm (2010) 1.65

The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis (2015) 1.63

Psychological distress and C-reactive protein: do health behaviours and pathophysiological factors modify the association? Eur Arch Psychiatry Clin Neurosci (2010) 1.60

Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int (2005) 1.55

C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization. Int J Obes (Lond) (2010) 1.53

Periodontal disease and systemic conditions: a bidirectional relationship. Odontology (2006) 1.52

Centrally located body fat is related to inflammatory markers in healthy postmenopausal women. Menopause (2008) 1.52

Fasting and postprandial markers of inflammation in lean and overweight children. Am J Clin Nutr (2009) 1.51

The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol (2008) 1.51

Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther (2010) 1.46

Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes (2014) 1.44

Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity. Cytokine (2008) 1.43

Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study. Endocr Relat Cancer (2010) 1.35

Changes in inflammatory biomarkers across weight classes in a representative US population: a link between obesity and inflammation. J Gastrointest Surg (2009) 1.34

C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study. Thorax (2005) 1.33

Disturbed sleep is associated with increased C-reactive protein in young women. Brain Behav Immun (2008) 1.31

Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy Pima Indians. Diabetes (2008) 1.29

PPARalpha in atherosclerosis and inflammation. Biochim Biophys Acta (2007) 1.28

Is neutrophil/lymphocyte ratio associated with subclinical inflammation and amyloidosis in patients with familial Mediterranean fever? Biomed Res Int (2013) 1.28

Body size phenotypes and inflammation in the Women's Health Initiative Observational Study. Obesity (Silver Spring) (2011) 1.27

Obesity and adipokines: effects on sympathetic overactivity. J Physiol (2012) 1.26

Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood. Clin Diagn Lab Immunol (2003) 1.21

The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med (2008) 1.21

Microarray analysis identifies matrix metalloproteinases (MMPs) as key genes whose expression is up-regulated in human adipocytes by macrophage-conditioned medium. Pflugers Arch (2009) 1.21

Endosperm and whole grain rye breads are characterized by low post-prandial insulin response and a beneficial blood glucose profile. Nutr J (2009) 1.21

Residential traffic exposure, pulse pressure, and C-reactive protein: consistency and contrast among exposure characterization methods. Environ Health Perspect (2010) 1.19

Inflammatory markers and gait speed decline in older adults. J Gerontol A Biol Sci Med Sci (2011) 1.18

Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat). Mediators Inflamm (2010) 1.17

Differences in atherosclerosis according to area level socioeconomic deprivation: cross sectional, population based study. BMJ (2009) 1.17

Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol (2013) 1.17

Systemic inflammation and the metabolic syndrome among middle-aged community volunteers. Metabolism (2010) 1.16

Inflammatory concepts of obesity. Int J Inflam (2011) 1.14

Obesity in cancer survival. Annu Rev Nutr (2012) 1.13

Metabolic syndrome: the danger signal in atherosclerosis. Vasc Health Risk Manag (2006) 1.13

Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. Int J Endocrinol (2013) 1.12

Association of inflammation with worsening HOMA-insulin resistance. Diabetologia (2009) 1.12

Elevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesity data from the InChianti study. Atherosclerosis (2008) 1.12

Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease. ISRN Gastroenterol (2011) 1.12

Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk. J Cardiovasc Transl Res (2011) 1.11

CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers. Am J Clin Pathol (2008) 1.10

Platelet counts and platelet activation markers in obese subjects. Mediators Inflamm (2008) 1.10

Efficacy of a meal replacement diet plan compared to a food-based diet plan after a period of weight loss and weight maintenance: a randomized controlled trial. Nutr J (2010) 1.09

Impact of obesity on bronchial asthma in Indian population. Lung India (2014) 1.08

Interleukin-6 production in human subcutaneous abdominal adipose tissue: the effect of exercise. J Physiol (2002) 1.08

The metabolic profile in patients with skin tags. Clin Exp Med (2009) 1.08

Stimulatory effect of voluntary exercise or fat removal (partial lipectomy) on apoptosis in the skin of UVB light-irradiated mice. Proc Natl Acad Sci U S A (2006) 1.07

Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia. Psychosom Med (2009) 1.07

The renaissance of C reactive protein. BMJ (2001) 1.07

Maternal serum C-reactive protein concentrations in early pregnancy and subsequent risk of preterm delivery. Clin Biochem (2007) 1.07

Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers. Ann Rheum Dis (2013) 1.07

Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax (2007) 1.06

Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies. PLoS One (2010) 1.06

Obesity and cognitive decline: role of inflammation and vascular changes. Front Neurosci (2014) 1.04

Hypoxia increases expression of selective facilitative glucose transporters (GLUT) and 2-deoxy-D-glucose uptake in human adipocytes. Biochem Biophys Res Commun (2007) 1.03

Vascular inflammation and endothelial dysfunction in experimental hypertension. Int J Hypertens (2011) 1.03

Endothelium and its alterations in cardiovascular diseases: life style intervention. Biomed Res Int (2014) 1.03

Caloric restriction with or without exercise: the fitness versus fatness debate. Med Sci Sports Exerc (2010) 1.02

Endothelial dysfunction in diabetes mellitus: possible involvement of endoplasmic reticulum stress? Exp Diabetes Res (2012) 1.02

Lifecourse socioeconomic trajectories and C-reactive protein levels in young adults: findings from a Brazilian birth cohort. Soc Sci Med (2010) 1.01

Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy. AIDS (2011) 1.01

Diet-induced obesity is associated with hyperleptinemia, hyperinsulinemia, hepatic steatosis, and glomerulopathy in C57Bl/6J mice. Endocrine (2009) 1.00

The interaction of adiposity with the CRP gene affects CRP levels: age, gene/environment susceptibilty-Reykjavik study. Int J Obes (Lond) (2009) 1.00

Association between insulin resistance and c-reactive protein among Peruvian adults. Diabetol Metab Syndr (2010) 0.99

The usefulness of circulating adipokine levels for the assessment of obesity-related health problems. Int J Med Sci (2008) 0.99

Inflammation, oxidative stress and renin angiotensin system in atherosclerosis. World J Biol Chem (2015) 0.99

Outcome of one-stage cementless exchange for acute postoperative periprosthetic hip infection. Clin Orthop Relat Res (2013) 0.99

Sleep variability, health-related practices, and inflammatory markers in a community dwelling sample of older adults. Psychosom Med (2010) 0.99

Inflammation in renal transplantation. Clin J Am Soc Nephrol (2009) 0.99

The relationship between low bone mass and metabolic syndrome in Korean women. Osteoporos Int (2009) 0.98

The levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese people. Clin Med Res (2010) 0.96

Plasma soluble gp130 levels are increased in older subjects with metabolic syndrome. The role of insulin resistance. Atherosclerosis (2010) 0.96

C-reactive protein causes insulin resistance in mice through Fcγ receptor IIB-mediated inhibition of skeletal muscle glucose delivery. Diabetes (2012) 0.96

Intersection between metabolic dysfunction, high fat diet consumption, and brain aging. J Neurochem (2010) 0.96

Coronary microvascular dysfunction in diabetes mellitus: A review. World J Cardiol (2010) 0.96

Evolutionary origins of insulin resistance: a behavioral switch hypothesis. BMC Evol Biol (2007) 0.95

Interleukin-1 and acute brain injury. Front Cell Neurosci (2015) 0.95

Comparative insights into the regulation of inflammation: levels and predictors of interleukin 6 and interleukin 10 in young adults in the Philippines. Am J Phys Anthropol (2011) 0.95

Characterizing and quantifying leukocyte populations in human adipose tissue: impact of enzymatic tissue processing. J Immunol Methods (2012) 0.95

Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA (2001) 8.56

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab (1997) 5.84

Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia (1999) 3.60

Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord (1998) 2.81

Monoclonal antibody PAL-E specific for endothelium. Lab Invest (1985) 2.37

Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet (2000) 2.26

Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care (2001) 2.15

The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II diabetic subjects. Diabetologia (2000) 2.14

[Clinical judgment and decision in practice. A patient with dyspnea]. Ned Tijdschr Geneeskd (1996) 1.71

No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice. Arterioscler Thromb Vasc Biol (2005) 1.70

ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study. J Intern Med (2009) 1.68

Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia (1999) 1.67

Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med (1986) 1.64

Leptin and the pituitary-thyroid axis: a comparative study in lean, obese, hypothyroid and hyperthyroid subjects. Clin Endocrinol (Oxf) (1998) 1.63

Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol (1999) 1.62

Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes (1996) 1.62

Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol (1999) 1.60

von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol (1999) 1.57

Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study. Kidney Int (1998) 1.56

Familial hyperhomocysteinaemia and endothelium-dependent vasodilatation and arterial distensibility of large arteries. Cardiovasc Res (1999) 1.54

Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol (1999) 1.51

[Periodic fever due to hyper-IgD syndrome]. Ned Tijdschr Geneeskd (2000) 1.48

Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes : 5-year follow-up of the Hoorn Study. Circulation (2000) 1.46

Analysis of twenty-four-hour ambulatory blood pressure monitoring: what time period to assess blood pressures during waking and sleeping? J Hypertens (1995) 1.44

Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes (1997) 1.44

Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol (1998) 1.42

Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation (1999) 1.42

Influence of sex hormones on plasma endothelin levels. Ann Intern Med (1993) 1.40

[Primary hyperaldosteronism as a cause of hypertension; diagnosis]. Ned Tijdschr Geneeskd (1996) 1.40

[Clinical judgment and decision making in clinical practice. A patient with fever and neck pain]. Ned Tijdschr Geneeskd (1996) 1.39

Effects of monocytopenia and anticoagulation in experimental Streptococcus sanguis endocarditis. Br J Exp Pathol (1980) 1.36

Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood (1988) 1.34

Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium. Blood (1985) 1.33

Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells. Biochem Biophys Res Commun (1983) 1.32

Effect of short-term fasting on lipid kinetics in lean and obese women. Am J Physiol (1999) 1.31

Comparison of blood pressure measurement methods. Lancet (1997) 1.29

Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia (2010) 1.27

Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes (2000) 1.27

Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. J Clin Endocrinol Metab (2001) 1.25

Regulation of fatty acid movement in human adipose tissue in the postabsorptive-to-postprandial transition. Am J Physiol (1994) 1.24

Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord (2003) 1.24

Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J Biol Chem (1990) 1.24

Insulin resistance, adipose tissue and coronary heart disease. Clin Sci (Lond) (1992) 1.17

Use of fibrinolytic agents in the prevention of postoperative adhesion formation. Fertil Steril (2000) 1.15

Increased plasma homocysteine after menopause. Atherosclerosis (2000) 1.14

The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study. Diabetes Care (1998) 1.14

The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome--an analysis by structural equation modelling. Int J Obes Relat Metab Disord (2002) 1.13

Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension (2001) 1.13

Coordinated regulation of hormone-sensitive lipase and lipoprotein lipase in human adipose tissue in vivo: implications for the control of fat storage and fat mobilization. Adv Enzyme Regul (1995) 1.12

Fatal varicella in a healthy young adult. Postgrad Med J (1985) 1.12

Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium. Arterioscler Thromb Vasc Biol (1997) 1.11

Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium. Biochim Biophys Acta (1984) 1.11

[Additional effects of statins independent of the cholesterol-lowering as yet not shown to be clinically relevant]. Ned Tijdschr Geneeskd (2000) 1.10

Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol (2001) 1.09

Metabolic characteristics of human adipose tissue in vivo. Clin Sci (Lond) (1989) 1.09

Ascites and a raised serum Ca 125--confusing combination. J R Soc Med (2001) 1.08

Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure. Diabetologia (1998) 1.08

Regulation of endothelial cell t-PA synthesis and release. Int J Hematol (1994) 1.08

Capillary recruitment is impaired in essential hypertension and relates to insulin's metabolic and vascular actions. Cardiovasc Res (2001) 1.07

Determinants of the limits of agreement between the sphygmomanometer and the SpaceLabs 90207 device for blood pressure measurement in health volunteers and insulin-dependent diabetic patients. J Hypertens (1998) 1.07

Simvastatin improves disturbed endothelial barrier function. Circulation (2000) 1.06

Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR). Eur J Clin Invest (2000) 1.05

Menopausal status and risk factors for cardiovascular disease. J Intern Med (1999) 1.05

Heterogeneity of cells isolated from rat liver by pronase digestion: ultrastructure, cytochemistry and cell culture. J Reticuloendothel Soc (1976) 1.05

Symptoms of depression in people with impaired glucose metabolism or Type 2 diabetes mellitus: The Hoorn Study. Diabet Med (2008) 1.04

Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study. Atherosclerosis (1999) 1.04

Sources and physiological significance of plasma dopamine sulfate. J Clin Endocrinol Metab (1999) 1.02

Hepatic clearance of tissue-type plasminogen activator in rats. Thromb Haemost (1985) 1.02

Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes Care (1999) 1.01

Studies on the acute release of tissue-type plasminogen activator from human endothelial cells in vitro and in rats in vivo: evidence for a dynamic storage pool. Blood (1995) 1.01

Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid (2001) 1.01

Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients. Nephrol Dial Transplant (1998) 1.00

Relation between number of cardiovascular risk factors/events and noninvasive Doppler ultrasound assessments of aortic compliance. Hypertension (1998) 0.99

Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients. Nephrol Dial Transplant (1997) 0.99

Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study. Diabetologia (2000) 0.99

Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction. Semin Thromb Hemost (2000) 0.99

Hyperhomocysteinemia is associated with the presence of retinopathy in type 2 diabetes mellitus: the Hoorn study. Arch Intern Med (2000) 0.99

Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study. Diabetes Care (1999) 0.99

Low density lipoprotein metabolism by endothelial cells from human umbilical cord arteries and veins. Arteriosclerosis (1984) 0.98

Short-term variability and sampling distribution of various parameters of urinary albumin excretion in patients with non-insulin-dependent diabetes mellitus. J Lab Clin Med (1998) 0.98

Endothelium-dependent and -independent vasodilation of large arteries in normoalbuminuric insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol (1996) 0.98

Giant-cell arteritis with normal erythrocyte sedimentation rate: case report and review of the literature. Neth J Med (1993) 0.97

Effects of tumour necrosis factor-alpha in the human forearm: blood flow and endothelin-1 release. Clin Sci (Lond) (2002) 0.97

Does metformin increase the serum total homocysteine level in non-insulin-dependent diabetes mellitus? J Intern Med (1997) 0.96

Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study. Arterioscler Thromb Vasc Biol (2001) 0.96

Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. J Vasc Surg (1994) 0.96

Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study. Diabetes Care (2000) 0.95

Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Obstet Gynecol (1995) 0.95

Immunoenzyme histochemical localization of fibrin degradation products in tissues. Am J Pathol (1981) 0.95

Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration. Arterioscler Thromb Vasc Biol (1998) 0.95

Hyperproinsulinaemia in impaired glucose tolerance is associated with a delayed insulin response to glucose. Diabetologia (1999) 0.95

The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning. Thromb Haemost (1998) 0.95

Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. Atherosclerosis (1998) 0.94

Role of the contact system in fibrinolysis. Semin Thromb Hemost (1987) 0.94